[go: up one dir, main page]

NO20091561L - Fremgangsmate for fremstilling av n-alkyl naltrekstronhalider - Google Patents

Fremgangsmate for fremstilling av n-alkyl naltrekstronhalider

Info

Publication number
NO20091561L
NO20091561L NO20091561A NO20091561A NO20091561L NO 20091561 L NO20091561 L NO 20091561L NO 20091561 A NO20091561 A NO 20091561A NO 20091561 A NO20091561 A NO 20091561A NO 20091561 L NO20091561 L NO 20091561L
Authority
NO
Norway
Prior art keywords
carbonate
preparation
naltrextron
halides
alkyl
Prior art date
Application number
NO20091561A
Other languages
English (en)
Norwegian (no)
Inventor
Alain Dlubala
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of NO20091561L publication Critical patent/NO20091561L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20091561A 2006-09-21 2009-04-20 Fremgangsmate for fremstilling av n-alkyl naltrekstronhalider NO20091561L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0608286A FR2906252B1 (fr) 2006-09-21 2006-09-21 Procede de preparation d'halogenures de n-aklyl naltrexone
PCT/FR2007/001516 WO2008034973A1 (fr) 2006-09-21 2007-09-19 Procede de preparation d'halogenures de n-alkyl naltrexone

Publications (1)

Publication Number Publication Date
NO20091561L true NO20091561L (no) 2009-06-16

Family

ID=38016779

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20091561A NO20091561L (no) 2006-09-21 2009-04-20 Fremgangsmate for fremstilling av n-alkyl naltrekstronhalider

Country Status (36)

Country Link
US (2) US7645880B2 (ru)
EP (1) EP2069362B1 (ru)
JP (1) JP5214615B2 (ru)
KR (1) KR101434693B1 (ru)
CN (2) CN102225939A (ru)
AR (1) AR062918A1 (ru)
AU (1) AU2007298855B2 (ru)
BR (1) BRPI0718440A2 (ru)
CA (1) CA2663509C (ru)
CL (1) CL2007002711A1 (ru)
CO (1) CO6170362A2 (ru)
CR (1) CR10660A (ru)
DO (1) DOP2011000307A (ru)
EA (1) EA015426B1 (ru)
ES (1) ES2531093T3 (ru)
FR (1) FR2906252B1 (ru)
GT (1) GT200900060A (ru)
HK (1) HK1135389A1 (ru)
HN (1) HN2009000503A (ru)
IL (1) IL197402A (ru)
JO (1) JO3023B1 (ru)
MA (1) MA30793B1 (ru)
ME (1) ME00613B (ru)
MX (1) MX2009003084A (ru)
MY (1) MY148094A (ru)
NI (1) NI200900035A (ru)
NO (1) NO20091561L (ru)
NZ (1) NZ575417A (ru)
PE (1) PE20080867A1 (ru)
SV (1) SV2009003192A (ru)
TN (1) TN2009000080A1 (ru)
TW (1) TWI465451B (ru)
UA (1) UA96957C2 (ru)
UY (1) UY30599A1 (ru)
WO (1) WO2008034973A1 (ru)
ZA (1) ZA200901846B (ru)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0809579B8 (pt) 2007-03-29 2021-05-25 Progenics Pharm Inc formas cristalinas e seus usos
WO2008138383A1 (de) 2007-05-16 2008-11-20 Cilag Ag Verfahren zur herstellung von n-methylnaltrexonbromid
WO2009009292A2 (en) * 2007-07-11 2009-01-15 Mallinckrodt Inc. Crystalline forms of naltrexone methobromide
EP2019105A1 (en) * 2007-07-19 2009-01-28 Siegfried Ltd. Process for the preparation of quaternary n-alkyl morphine or morphinane alkaloid derivatives
US8080661B2 (en) * 2008-09-30 2011-12-20 Mallinckrodt Llc Processes for the synthesis of tertiary amines
WO2010096788A1 (en) * 2009-02-23 2010-08-26 Mallinckrodt Inc. (+)-morphinanium quaternary salts and processes for their production
US8563724B2 (en) * 2009-02-23 2013-10-22 Mallinckrodt Llc (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives
US8563727B2 (en) * 2009-02-23 2013-10-22 Mallinckrodt Llc (+)-morphinanium N-oxides and processes for their production
US8946419B2 (en) 2009-02-23 2015-02-03 Mallinckrodt Llc (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives
JP5824448B2 (ja) 2009-04-24 2015-11-25 ブロック ユニバーシティ モルフィナンおよびモルフィノン化合物の調製法
WO2011009020A2 (en) 2009-07-16 2011-01-20 Mallinckrodt Inc. Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers
CN101845047B (zh) * 2009-12-31 2011-12-07 南京臣功制药有限公司 一种溴甲基纳曲酮的制备方法
AP3415A (en) 2010-11-05 2015-09-30 Lundbeck & Co As H Method for manufacturing of naltrexone
US8580963B2 (en) 2010-11-05 2013-11-12 H. Lundbeck A/S Method for the manufacturing of naltrexone
JO3209B1 (ar) * 2010-11-05 2018-03-08 H Lundbeck As طريقة لتصنيع نالتريكسون
WO2012138888A1 (en) 2011-04-05 2012-10-11 Alkermes, Inc. Process for the synthesis of quaternary amine compounds
ES2566620T3 (es) 2011-09-08 2016-04-14 Mallinckrodt Llc Procesamiento de alcaloides sin el aislamiento de intermedios
CN103172640A (zh) * 2011-12-22 2013-06-26 天津康鸿医药科技发展有限公司 一种(r)-n-溴甲基纳曲酮的制备方法以及纳曲酮衍生物
AR090916A1 (es) 2012-05-03 2014-12-17 Lundbeck & Co As H Metodo para la fabricacion de naltrexona
CN105985348B (zh) * 2015-02-12 2019-02-01 正大天晴药业集团股份有限公司 一种溴甲基纳曲酮的制备方法
CN106317064B (zh) * 2015-06-30 2018-06-19 北大方正集团有限公司 溴甲纳曲酮的制备方法
KR102201609B1 (ko) * 2019-04-19 2021-01-12 연성정밀화학(주) 날데메딘의 제조방법
CN111777617A (zh) * 2020-07-10 2020-10-16 华润三九医药股份有限公司 一种溴甲纳曲酮的精制方法
CA3194746A1 (en) 2020-10-06 2022-04-14 Tien-Li Lee Oral delayed burst formulation of low-dose naltrexone or naloxone used for|treating fibromyalgia and long covid

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4176186A (en) * 1978-07-28 1979-11-27 Boehringer Ingelheim Gmbh Quaternary derivatives of noroxymorphone which relieve intestinal immobility
JP2006509745A (ja) * 2002-11-08 2006-03-23 マリンクロッド・インコーポレイテッド 第四級ｎ−アルキルモルフィナンアルカロイド塩の製造方法
AR057325A1 (es) * 2005-05-25 2007-11-28 Progenics Pharm Inc Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos

Also Published As

Publication number Publication date
CN102225939A (zh) 2011-10-26
ES2531093T3 (es) 2015-03-10
MA30793B1 (fr) 2009-10-01
NI200900035A (es) 2010-01-26
BRPI0718440A2 (pt) 2013-11-19
EA200970307A1 (ru) 2009-12-30
MEP10509A (en) 2011-12-20
FR2906252A1 (fr) 2008-03-28
HK1135389A1 (en) 2010-06-04
DOP2011000307A (es) 2011-10-31
IL197402A (en) 2012-12-31
KR20090057031A (ko) 2009-06-03
HN2009000503A (es) 2011-03-02
EP2069362A1 (fr) 2009-06-17
CA2663509C (fr) 2014-03-18
US7645880B2 (en) 2010-01-12
CN101516892B (zh) 2012-06-20
IL197402A0 (en) 2009-12-24
TN2009000080A1 (en) 2010-08-19
KR101434693B1 (ko) 2014-08-27
US20100145051A1 (en) 2010-06-10
TW200821314A (en) 2008-05-16
TWI465451B (zh) 2014-12-21
JO3023B1 (ar) 2016-09-05
AU2007298855B2 (en) 2012-09-13
JP2010504308A (ja) 2010-02-12
PE20080867A1 (es) 2008-08-22
JP5214615B2 (ja) 2013-06-19
EP2069362B1 (fr) 2014-07-09
UA96957C2 (ru) 2011-12-26
CL2007002711A1 (es) 2008-04-18
WO2008034973A1 (fr) 2008-03-27
CA2663509A1 (fr) 2008-03-27
ZA200901846B (en) 2010-07-28
FR2906252B1 (fr) 2008-11-28
MX2009003084A (es) 2009-04-02
US20080214817A1 (en) 2008-09-04
UY30599A1 (es) 2008-05-02
US8288547B2 (en) 2012-10-16
CO6170362A2 (es) 2010-06-18
AR062918A1 (es) 2008-12-17
CR10660A (es) 2009-06-24
NZ575417A (en) 2011-09-30
CN101516892A (zh) 2009-08-26
GT200900060A (es) 2011-01-04
EA015426B1 (ru) 2011-08-30
SV2009003192A (es) 2009-10-27
AU2007298855A1 (en) 2008-03-27
MY148094A (en) 2013-02-28
ME00613B (me) 2011-12-20

Similar Documents

Publication Publication Date Title
NO20091561L (no) Fremgangsmate for fremstilling av n-alkyl naltrekstronhalider
UA87389C2 (ru) Способ получения тризамещенных солей метилглицин-n,n-диуксусной кислоты и катионов щелочных металлов
WO2007149906A3 (en) Stabilized composition for producing chlorine dioxide
WO2009034932A1 (ja) アルカリ型非イオン性界面活性剤組成物
PL1874762T3 (pl) Sposób otrzymywania 5-(4-[4-(5-cyjano-3-indolilo)butylo]-1-piperazynylo)benzofurano-2-karboksyamidu
NO20082116L (no) Kjemisk fremgangsmate for fremstilling av en amido-fenoksybenzosyreforbindelse
BR0215555A (pt) Preparação de reagentes de bromação não perigosos
CA2547743A1 (en) Improved method for bisulfite treatment
NO20064884L (no) Kjemisk fremgangsmate og ny krystallinsk form
FR2836681B1 (fr) Compose phosphocalcique modifie, composition injectable le contenant
HRP20160853T1 (hr) Postupak za proizvodnju 3-okso-pregn-4-en-21,17-karbolaktona pomoću bezmetalne oksidacije 17-(3-hidroksipropil)-3,17-dihidroksiandrostana
NO20060258L (no) Nematicidale tiazolin-inneholdende fluorobutener
BRPI0411195A (pt) método para a preparação de uma oxazinona fundida e método para a preparação de um composto
WO2008001392A3 (en) An improved process for the preparation of pantoprazole and its pharmaceutically acceptable salts
MX274842B (es) Procedimiento para la produccion de sales de (4,5-dihidroisoxazol- 3-il)tiocarboxamidina.
NO20076358L (no) Fremgangsmate for syntese av sulfonylhalider og sulfonamider fra sulfonsyresalter
PL1891191T3 (pl) Granulaty bentonitowe ulegające szybkiemu rozkładowi
WO2008077035A3 (en) Processes for the preparation of levetiracetam
TH135001A (th) กรรมวิธีสำหรับการเตรียม n-แอลคิลแนลเทรกโซนเฮไลด์
ITMI20060488A1 (it) Procedimento per la preparazione di 3,4-bis trifluoronetil-n-metilbenzilammina
NO20044708L (no) Fremgangsmate for fremstilling av halogenidsaltopplosning
WO2007129184A3 (en) An improved process for the preparation of phenytoin sodium
ZA200805255B (en) Ethanolic and/or aqueous composition of an ammoniacal solution of alkaline metal salts of azide, mainly sodium & potassium
RU2007149526A (ru) Гидраты солей щелочноземельных металлов и ирбесартана и их получение
DOP2009000041A (es) Procedimiento de preparacion de halogenuros de n-alquil-naltrexona

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application